Long-term olanzapine therapy in the treatment of bipolar I disorder: An open-label continuation phase study

Journal of Clinical Psychiatry

Volumn 62, Issue 4, 2001, Pages 273-281

  Sanger, T M ^a   Grundy, S L ^a   Gibson, P J ^a   Namjoshi, M A ^a   Greaney, M G ^a   Tohen, M F ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; LITHIUM; OLANZAPINE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; HAMILTON SCALE; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MANIC DEPRESSIVE PSYCHOSIS; MONOTHERAPY; PRIORITY JOURNAL; RATING SCALE; RELAPSE; REMISSION; SOMNOLENCE; TREATMENT OUTCOME; WEIGHT GAIN;

EID: 0035002883     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n0410     Document Type: Article

References (43)

1. Affective disorders
2. Course of illness and maintenance treatment for patients with bipolar disorder
3. Antipsychotics in bipolar disorder
4. Maintenance clinical trials in bipolar disorder: Design implications of the divalproex-lithium-placebo study
5. Long term treatment of bipolar disorder
6. The role of antipsychotic agents in the treatment of bipolar disorder patients
7. Anticonvulsants and antipsychotics in the treatment of bipolar disorder
8. Étude comparative du valpromide versus lithium dans la prophylaxie des troubles thymiques
9. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder
10. Lithium and the anticonvulsants in the treatment of bipolar disorder
11. Comparison of lithium carbonate and chlorpromazine in the treatment of mania: Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group
12. Flupenthixol decanoate in recurrent manic-depressive illness
13. Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients
14. The role of neuroleptics in manic-depressive illness
15. Tardive dyskinesia: Prevalence and risk factors, 1959 to 1979
16. Lithium tremor
17. Course of the manicdepressive cycle and changes caused by treatment
18. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia
19. Clozapine in severe mood disorders
20. Safety and efficacy of risperidone as combination therapy to mood stabilizers in the treatment of bipolar disorder
21. Risperidone compared with both lithium and haloperidol in mania: A double-blind randomized controlled trial
22. The use of quetiapine for treatment-resistant bipolar disorder: A case series
23. Quetiapine fumarate in neuroleptic-dependent mood disorders
24. Olanzapine versus placebo in the treatment of acute mania
25. Olanzapine in the treatment of mania: A placebo-controlled four-week study
26. Olanzapine versus divalproex for the treatment of acute mania
27. Efficacy of olanzapine added to valproate or lithium in the treatment of bipolar I disorder
28. A rating scale for mania: Reliability, validity and sensitivity
29. Development of a rating scale for primary depressive illness
30. Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): The CGI-BP
31. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
32. Concurrent validity of the cognitive component of schizophrenia: Relationship of PANSS scores to neuropsychological assessments
33. A rating scale for extrapyramidal side effects
34. A rating scale for drug-induced akathisia
35. Research diagnoses for tardive dyskinesia
36. Psychomotor, cognitive, extrapyramidal, and affective functions of healthy volunteers during treatment with an atypical (amisulpiride) and a classic (haloperidol) antipsychotic
37. Nicotine-haloperidol interactions and cognitive performance in schizophrenics
38. Maintenance lithium treatment: Side effects and compliance